TY - JOUR
T1 - Ligand density at the surface of a nanoparticle and different uptake mechanism
T2 - Two important factors for successful siRNA delivery to liver endothelial cells
AU - Akhter, Afsana
AU - Hayashi, Yasuhiro
AU - Sakurai, Yu
AU - Ohga, Noritaka
AU - Hida, Kyoko
AU - Harashima, Hideyoshi
N1 - Funding Information:
This study was supported by grants from the Special Education and Research Expenses of the Ministry of Education, Culture, Sports, Science and Technology of Japan . The authors also wish to thank Dr. Milton S. Feather for his helpful advice in writing the English manuscript.
Publisher Copyright:
© 2014 Elsevier B.V. All rights reserved.
PY - 2014/11/20
Y1 - 2014/11/20
N2 - The specific delivery of a gene to liver sinusoidal endothelial cells (LSEC) could become a useful strategy for treating various liver diseases associated with such cells. We previously reported that the accumulation of KLGR peptide modified liposomes through liver sinusoidal blood vessels was enhanced after an intravenous administration. Here, we report on an attempt to develop an LSEC targeted nanocarrier system to deliver siRNA for the successful knockdown of LSEC specific gene expression. The system involved the development of a multifunctional envelop-type nano device (MEND) modified with the KLGR peptide for siRNA delivery targeting LSEC. Our developed carrier successfully lowered specific gene expression in LSEC. An in vivo study showed that at a lower density of ligand at the surface of the MEND resulted in the highest knockdown of gene expression in LSEC. This is the first report of the successful delivery of siRNA to LSECs. Further experiments suggest that not only a higher endosomal escape efficiency into the cytosol but also the uptake mechanism as a function of ligand density are two important factors to be considered for targeting LSEC.
AB - The specific delivery of a gene to liver sinusoidal endothelial cells (LSEC) could become a useful strategy for treating various liver diseases associated with such cells. We previously reported that the accumulation of KLGR peptide modified liposomes through liver sinusoidal blood vessels was enhanced after an intravenous administration. Here, we report on an attempt to develop an LSEC targeted nanocarrier system to deliver siRNA for the successful knockdown of LSEC specific gene expression. The system involved the development of a multifunctional envelop-type nano device (MEND) modified with the KLGR peptide for siRNA delivery targeting LSEC. Our developed carrier successfully lowered specific gene expression in LSEC. An in vivo study showed that at a lower density of ligand at the surface of the MEND resulted in the highest knockdown of gene expression in LSEC. This is the first report of the successful delivery of siRNA to LSECs. Further experiments suggest that not only a higher endosomal escape efficiency into the cytosol but also the uptake mechanism as a function of ligand density are two important factors to be considered for targeting LSEC.
KW - ApoB 100
KW - KLGR peptide
KW - Liver sinusoidal endothelial cell
KW - siRNA
UR - http://www.scopus.com/inward/record.url?scp=84907207630&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84907207630&partnerID=8YFLogxK
U2 - 10.1016/j.ijpharm.2014.08.048
DO - 10.1016/j.ijpharm.2014.08.048
M3 - Article
C2 - 25169077
AN - SCOPUS:84907207630
SN - 0378-5173
VL - 475
SP - 227
EP - 237
JO - International Journal of Pharmaceutics
JF - International Journal of Pharmaceutics
IS - 1
ER -